Biomea Fusion, Inc. Variable Lease, Cost
Biomea Fusion, Inc. (BMEA) reported Variable Lease, Cost of $1.06 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-03-24
- Biomea Fusion, Inc. variable lease, cost for the quarter ending 2024-03-31 was $381.00K, a 55.51% increase year-over-year.
- Biomea Fusion, Inc. variable lease, cost for the quarter ending 2023-12-31 was $401.00K, a 186.43% increase year-over-year.
- Biomea Fusion, Inc. variable lease, cost for the quarter ending 2023-09-30 was $358.00K, a 397.22% increase year-over-year.
- Biomea Fusion, Inc. variable lease, cost for the quarter ending 2023-06-30 was $322.00K, a 347.22% increase year-over-year.
- Biomea Fusion, Inc. variable lease, cost for fiscal 2025 was $1.06M, a 6.23% increase from fiscal 2024.
- Biomea Fusion, Inc. variable lease, cost for fiscal 2024 was $995.00K, a 24.96% decline from fiscal 2023.
- Biomea Fusion, Inc. variable lease, cost for fiscal 2023 was $1.33M, a 271.43% increase from fiscal 2022.
- Biomea Fusion, Inc. variable lease, cost for fiscal 2022 was $357.00K, a 240.00% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.06M 10-K · filed 2026-03-24 | |||
| 2024-12-31 | $995.00K 10-K · filed 2026-03-24 | |||
| 2024-03-31 | $381.00K 10-Q · filed 2024-05-02 | $782.00K derived: sum of 2 quarters · filed 2026-03-24 | $1.14M derived: sum of 3 quarters · filed 2026-03-24 | $1.46M derived: sum of 4 quarters · filed 2026-03-24 |
| 2023-12-31 | $401.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $759.00K derived: sum of 2 quarters · filed 2026-03-24 | $1.08M derived: sum of 3 quarters · filed 2026-03-24 | $1.33M 10-K · filed 2026-03-24 |
| 2023-09-30 | $358.00K 10-Q · filed 2023-10-30 | $680.00K derived: sum of 2 quarters · filed 2023-10-30 | $925.00K 10-Q · filed 2023-10-30 | $1.06M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-06-30 | $322.00K 10-Q · filed 2023-07-31 | $567.00K 10-Q · filed 2023-07-31 | $707.00K derived: sum of 3 quarters · filed 2025-03-31 | $779.00K derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-03-31 | $245.00K 10-Q · filed 2024-05-02 | $385.00K derived: sum of 2 quarters · filed 2025-03-31 | $457.00K derived: sum of 3 quarters · filed 2025-03-31 | $529.00K derived: sum of 4 quarters · filed 2025-03-31 |
| 2022-12-31 | $140.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $212.00K derived: sum of 2 quarters · filed 2025-03-31 | $284.00K derived: sum of 3 quarters · filed 2025-03-31 | $357.00K 10-K · filed 2025-03-31 |
| 2022-09-30 | $72.00K 10-Q · filed 2023-10-30 | $144.00K derived: sum of 2 quarters · filed 2023-10-30 | $217.00K 10-Q · filed 2023-10-30 | |
| 2022-06-30 | $72.00K 10-Q · filed 2023-07-31 | $213.00K 10-Q · filed 2023-07-31 | ||
| 2022-03-31 | $141.00K 10-Q · filed 2023-05-02 | |||
| 2021-12-31 | $105.00K 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |